In simple steatosis and early metabolic dysfunction-associated steatohepatitis (MASH), many of the body composition and metabolic features predisposing to MASLD/MASH contribute to decreased GH and IGF-I levels. The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatotic liver disease.